Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing of Respiratory Specimens for the Validation of the QIAGEN ResPlex II Advanced Panel Test and the Artus Influenza A/B RT-PCR Test

NCT01302418 is registered in ClinicalTrials.gov with QIAGEN Gaithersburg, Inc as lead sponsor.

NCT NCT01302418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01302418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing of Respiratory Specimens for the Validation of the QIAGEN ResPlex II Advanced Panel Test and the Artus Influenza A/B RT-PCR Test
Lead sponsor
QIAGEN Gaithersburg, Inc
Phase
Observational
Overall status
Completed
Start date
February 28, 2011
Completion date
November 30, 2011
Enrollment
272 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

adenovirus types b/c/e, artus influenza a/b rt-pcr test, coronavirus subtype hku1, coronavirus subtype nl63, coronavirus subtype oc43, coronavirus subtypes 229e, coxsackie virus/echovirus, human bocavirus, human metapneumovirus a/b, infection due to human parainfluenza virus 1, influenza a, influenza b, parainfluenza type 2, parainfluenza type 3, parainfluenza type 4, qiagen resplex ii advanced panel, respiratory syncytial virus infections, rhinovirus